Biocompatibility analysis of an electrically-activated silver-based antibacterial surface system for medical device applications

Journal of Materials Science: Materials in Medicine

Volumn 24, Issue 3, 2013, Pages 755-760

  Samberg, Meghan E ^a,b,c,d   Tan, Zhuo ^b   Monteiro Riviere, Nancy A ^a,c,e   Orndorff, Paul E ^a   Shirwaiker, Rohan A ^b,c  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b North Carolina State University   (United States)

^c Biomedical Research Imaging Center   (United States)

^d US ARMY INSTITUTE OF SURGICAL RESEARCH   (United States)

^e KANSAS STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBACTERIAL EFFICACY; ANTIBACTERIAL SURFACES; DIRECT ELECTRIC CURRENTS; HUMAN DERMAL FIBROBLASTS; HUMAN EPIDERMAL KERATINOCYTES; NORMAL HUMAN OSTEOBLASTS; SURGICAL SITE INFECTIONS; TECHNOLOGICAL APPLICATIONS;

BACTERIA; ESCHERICHIA COLI; HEALTH CARE; METAL IONS; SILVER; SURGICAL EQUIPMENT; TISSUE; TOXICITY;

BIOCOMPATIBILITY;

SILVER;

ANTIBACTERIAL ACTIVITY; ARTICLE; BIOCOMPATIBILITY; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DIRECT CURRENT; DISEASE TRANSMISSION; DRUG EFFICACY; ELECTRIC CURRENT; ELECTRODE; EPIDERMIS CELL; ESCHERICHIA COLI; FIBROBLAST; HUMAN; HUMAN CELL; INFECTION PREVENTION; KERATINOCYTE; LOW INTENSITY DIRECT ELECTRIC CURRENT; MEDICAL DEVICE; OSTEOBLAST; PRIORITY JOURNAL; PROPHYLACTIC SURFACE SYSTEM; SKIN CELL; STAPHYLOCOCCUS AUREUS; SURFACE PROPERTY;

ANTI-BACTERIAL AGENTS; BIOCOMPATIBLE MATERIALS; EQUIPMENT AND SUPPLIES; ESCHERICHIA COLI; MICROBIAL SENSITIVITY TESTS; SILVER; STAPHYLOCOCCUS AUREUS; SURFACE PROPERTIES;

ESCHERICHIA COLI; STAPHYLOCOCCUS AUREUS;

EID: 84876410058     PISSN: 09574530     EISSN: 15734838     Source Type: Journal    
DOI: 10.1007/s10856-012-4838-5     Document Type: Article

References (24)

1. Edwards JR, Peterson KD, Mu Y, Banerjee S, Allen-Bridson K, Morrell G, Dudeck MA, Pollock DA, Horan TC. National Healthcare Safety Network (NHSN) report: data summary for 2006 through 2008. Am J Infect Control. 2009;37:783-805.
2. CDC. National Hospital Discharge Survey: number, rate, and standard error of all-listed surgical and nonsurgical procedures for discharges from short-stay hospitals, by selected procedure. National Center for Health Statistics. 2009. p. 1-3.
3. Hall MJ, Owings MF. National Hospital Discharge Survey. Advance Data from Vital and Health Statistics. United States: Centers for Disease Control and Prevention (CDC); 2000. p. 1-19.
4. Ziegler-Graham K, et al. Estimating the prevalence of limb loss in the United States: 2005 to 2050. Arch Phys Med Rehab. 2008;89:422-9.
5. Del Pozo JL, Patel R. Infection associated with prosthetic joints. N Engl J Med. 2009;361:787-94.
6. Whitehouse JD, Friedman ND, Kirkland KB, Richardson WJ, Sexton DJ. The impact of surgical-site infections following orthopedic surgery at a community hospital and a university hospital: adverse quality of life, excess length of stay, and extra cost. Infect Cont Hosp Epidemiol. 2002;23(4):183-9.
7. AAOS. Orthopaedic infection prevention and control: an emerging new paradigm. American Academy of Orthopaedic Surgeons. Proceedings from 77th annual meeting. 2010;1-6.
8. Cabrita H, Croci A, De Camargo O, De Lima A. Prospective study of the treatment of infected hip arthroplasties with or without the use of an antibiotic-loaded spacer. Clinics (Sao Paulo). 2007;62:99-108.
9. Tu J, Yu M, Lu Y, Cheng K, Weng W, Lin J, Wang H, Du P, Han G. Preparation and antibiotic drug release of mineralized collagen coatings on titanium. J Mater Sci-Mater M. 2012; doi: 10.1007/s10856-012-4692-5.
10. Samberg ME, Monteiro-Riviere NA. In vitro and in vivo toxicity of silver nanoparticles. In: Bhushan B, editor. Encyclopedia of nanotechnology, vol. 10. Heidelberg: Springer; 2012. p. 1069-77.
11. Lok CN, Ho CM, Chen R, He QY, Yu WY, Sun H, Tam PK, Chiu JF, Chen CM. Proteomic analysis of the mode of antibacterial action of silver nanoparticles. J Proteome Res. 2006;5:916-24.
12. Panácek A, Kvítek L, Prucek R, Kolář M, Veceřová R, Pizúrova N, Sharma V, Nevěcná T, Zbořil R. Silver colloid nanoparticles: synthesis, characterization, and their antimicrobial activity. J Phys Chem B. 2006;110:16248-53.
13. Samberg ME, Orndorff PE, Monteiro-Riviere NA. Antibacterial efficacy of silver nanoparticles of different sizes, surface conditions and synthesis methods. Nanotoxicology. 2011;5(2):244-53.
14. Bologna RA, Tu LM, Polansky M, Fraimow HD, Gordon DA, Whitmore KE. Hydrogel/silver ion-coated urinary catheter reduces nosocomial urinary tract infection rates in intensive care unit patients: a multicenter study. Urology. 1999;54(6):982-7.
15. Massè A, Bruno A, Bosetti M, Biasibetti A, Cannas M, Gallinaro P. Prevention of pin track infection in external fixation with silver coated pins: clinical and microbiological results. J Biomed Mater Res. 2000;5(53):600-4.
16. Sheehan E, McKenna J, Mulhall KJ, Marks P, McCormack D. Adhesion of Staphylococcus to orthopaedic metals, an in vivo study. J Orthop Res. 2004;22:39-43.
17. Fuller T, Wysk R, Charumani C, Kennett M, Sebastiennelli W, Abrahams R, Shirwaiker RA, Voigt R, Royer P. Developing an engineered antimicrobial/ prophylactic system using electrically activated bactericidal metals. J Mater Sci-Mater M. 2010;21(7):2103-14.
18. Singh R, Singh D. Radiation synthesis of PVP/alginate hydrogel containing nanosilver as wound dressing. J Mater Sci-Mater M. 2012; doi: 10.1007/s10856-012-4730-3.
19. Shirwaiker RA, Wysk RA, Kariyawasam S, Carrion H, Voigt RC. Micro-scale fabrication and characterization of a silver-polymer based electrically activated antibacterial surface. Biofabrication. 2011;3(1):015003.
20. Shirwaiker RA. The characterization of the antibacterial efficacy of an electrically activated silver ion-based surface system. University Park: The Pennsylvania State University; 2011.
21. Hussain SM, Hess KL, Gearhart JM, Geiss KT, Schlager JJ. In vitro toxicity of nanoparticles in BRL 3A rat liver cells. Toxicol In Vitro. 2005;19(7):975-83.
22. Kim S, Choi JE, Choi J, Chung K-H, Park K, Yi J, Ryu D-Y. Oxidative stress-dependent toxicity of silver nanoparticles in human hepatoma cells. Toxicol In Vitro. 2009;23(6):1076-84.
23. Park E-J, Yi J, Kim Y, Choi K, Park K. Silver nanoparticles induce cytotoxicity by a Trojan-horse type mechanism. Toxicol In Vitro. 2010;24(3):872-8.
24. Samberg ME, Oldenburg SJ, Monteiro-Riviere NA. Evaluation of silver nanoparticle toxicity in skin in vivo and keratinocytes in vitro. Environ Health Perspect. 2010;118:407-13.